Evidence map›Paper›PMID 35000796›Full record

ReviewGynecologic oncology2022

Creating work environments where people of all genders in gynecologic oncology can thrive: An SGO evidence-based review.

S M Temkin, E Chapman-Davis, N Nair, D E Cohn, J F Hines, E C Kohn, S V Blank

Abstract readReview
In one paragraph

Review in Gynecologic oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Patients' sexual harassment of nurses and nursing students: A cross-sectional study.International journal of nursing studies advances · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

S M TemkinClinical Research, Office on Research for Women's Health, National Institutes of Health, Bethesda, MD, USA.
E Chapman-DavisObstetrics and Gynecology, Weill Cornell Medical College, New York, NY, USA.
N NairLouisiana State University Health Sciences Center, New Orleans, LA, USA.
D E CohnArthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
J F HinesWellStar Medical Group, Smyrna, GA, USA.
E C KohnGynecologic Cancer Therapeutics, Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD, USA.
S V BlankGynecologic Oncology for the Mount Sinai Health System, Icahn School of Medicine at Mount Sinai and the Blavatnik Family Women's Health Research Institute, New York, NY, USA. Electronic address: Stephanie.Blank@mountsinai.org.

Funding

Intramural NIH HHS Z99 CA999999
6 · The paper itself

Abstract

Equality, equity, and parity in the workplace are necessary to optimize patient care across all aspects of medicine. Gender-based inequities remain an obstacle to quality of care, including within the now majority women subspecialty of gynecologic oncology. The results of the 2020 SGO State of the Society Survey prompted this evidence-based review. Evidence related to relevant aspects of the clinical care model by which women with malignancies are cared for is summarized. Recommendations are made that include ways to create work environments where all members of a gynecologic oncology clinical care team, regardless of gender, can thrive. These recommendations aim to improve equality and equity within the specialty and, in doing so, elevate the care that our patients receive.

Indexed as

Genital Neoplasms, FemaleWorkplaceFemaleHumansMaleSurveys and QuestionnairesGender discriminationGender equityGynecologic oncologyQuality of careSexual harassment

Identifiers

PMID35000796
PMCPMC9465952

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.